<VariationArchive VariationID="1202576" VariationName="NM_014363.6(SACS):c.4756_4760del (p.Asn1586fs)" VariationType="Deletion" Accession="VCV001202576" Version="15" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2021-08-19" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1191511" VariationID="1202576">
      <GeneList>
        <Gene Symbol="SACS" FullName="sacsin molecular chaperone" GeneID="26278" HGNC_ID="HGNC:10519" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q12.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="23328830" stop="23433702" display_start="23328830" display_stop="23433702" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="23902964" stop="24007840" display_start="23902964" display_stop="24007840" Strand="-" />
          </Location>
          <OMIM>604490</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014363.6(SACS):c.4756_4760del (p.Asn1586fs)</Name>
      <CanonicalSPDI>NC_000013.11:23339115:TGATTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q12.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="23339116" stop="23339120" display_start="23339116" display_stop="23339120" variantLength="5" positionVCF="23339115" referenceAlleleVCF="ATGATT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="23913255" stop="23913259" display_start="23913255" display_stop="23913259" variantLength="5" positionVCF="23913254" referenceAlleleVCF="ATGATT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>N1439fs</ProteinChange>
      <ProteinChange>N1586fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278055.2" sequenceAccession="NM_001278055" sequenceVersion="2" change="c.4315_4319del">
            <Expression>NM_001278055.2:c.4315_4319del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001264984.1" sequenceAccession="NP_001264984" sequenceVersion="1" change="p.Asn1439fs">
            <Expression>NP_001264984.1:p.Asn1439fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014363.6" sequenceAccession="NM_014363" sequenceVersion="6" change="c.4756_4760del" MANESelect="true">
            <Expression>NM_014363.6:c.4756_4760del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055178.3" sequenceAccession="NP_055178" sequenceVersion="3" change="p.Asn1586fs">
            <Expression>NP_055178.3:p.Asn1586fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014363.4" sequenceAccession="NM_014363" sequenceVersion="4" change="c.4756_4760delAATCA">
            <Expression>NM_014363.4:c.4756_4760delAATCA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014363.5" sequenceAccession="NM_014363" sequenceVersion="5" change="c.4756_4760delAATCA">
            <Expression>NM_014363.5:c.4756_4760delAATCA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.23913256_23913260del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.23913256_23913260del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.23339117_23339121del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.23339117_23339121del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012342.1" sequenceAccession="NG_012342" sequenceVersion="1" change="g.99583_99587del">
            <Expression>NG_012342.1:g.99583_99587del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="765361868" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014363.6(SACS):c.4756_4760del (p.Asn1586fs) AND not provided" Accession="RCV001568302" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014363.6(SACS):c.4756_4760del (p.Asn1586fs) AND Charlevoix-Saguenay spastic ataxia" Accession="RCV001832778" Version="1">
        <ClassifiedConditionList TraitSetID="1544">
          <ClassifiedCondition DB="MedGen" ID="C1849140">Charlevoix-Saguenay spastic ataxia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-05-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014363.6(SACS):c.4756_4760del (p.Asn1586fs) AND Hereditary spastic paraplegia" Accession="RCV001847304" Version="3">
        <ClassifiedConditionList TraitSetID="8750">
          <ClassifiedCondition DB="MedGen" ID="C0037773">Hereditary spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014363.6(SACS):c.4756_4760del (p.Asn1586fs) AND Spastic paraplegia" Accession="RCV001866008" Version="5">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-17" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2021-08-19" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19892370</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21745802</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27871429</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30460542</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8750" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14327" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia</ElementValue>
                <XRef ID="Hereditary+spastic+paraplegia/3383" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019064" DB="MONDO" />
                <XRef ID="39912006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial spastic paraparesis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FSP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6637" />
                <XRef ID="6637" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500218" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525863" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592992" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529007" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500041" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525862" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508756" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301682</ID>
                <ID Source="BookShelf">NBK1509</ID>
              </Citation>
              <XRef ID="685" DB="Orphanet" />
              <XRef ID="C0037773" DB="MedGen" />
              <XRef ID="MONDO:0019064" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS303350" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1544" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5931" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charlevoix-Saguenay spastic ataxia</ElementValue>
                <XRef ID="MONDO:0010041" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive spastic ataxia of Charlevoix-Saguenay</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic ataxia of Charlevoix-Saguenay</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPAX6</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ARSACS</ElementValue>
                <XRef ID="NBK1255" DB="GeneReviews" />
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SACS</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4910" />
                <XRef ID="4910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is clinically characterized by a progressive cerebellar ataxia, peripheral neuropathy, and spasticity. Disease onset of classic ARSACS is often in early childhood, leading to delayed walking because of gait unsteadiness in very young toddlers, while an increasing number of individuals with disease onset in teenage or early-adult years are now being described. Typically the ataxia is followed by lower-limb spasticity and later by peripheral neuropathy â€“ although pronounced peripheral neuropathy has been observed as a first sign of ARSACS. Oculomotor disturbances, dysarthria, and upper-limb ataxia develop with slower progression than the other findings. Brain imaging demonstrates atrophy of the superior vermis and the cerebellar hemisphere with additional findings on MRI, such as linear hypointensities in the pons and hyperintense rims around the thalami. Many affected individuals (though not all) have yellow streaks of hypermyelinated fibers radiating from the edges of the optic disc noted on ophthalmologic exam, and thickened retinal fibers can be demonstrated by optical coherence tomography. Mild intellectual disability, hearing loss, and urinary urgency and incontinence have been reported in some individuals.</Attribute>
                <XRef ID="NBK1255" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301432</ID>
                <ID Source="BookShelf">NBK1255</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/ENS, 2014">
                <ID Source="PubMed">24418350</ID>
              </Citation>
              <XRef ID="98" DB="Orphanet" />
              <XRef ID="C1849140" DB="MedGen" />
              <XRef ID="MONDO:0010041" DB="MONDO" />
              <XRef Type="MIM" ID="270550" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4082356" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_014363.6:c.4756_4760del|Charlevoix-Saguenay type spastic ataxia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002086270" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.6:c.4756_4760del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Charlevoix-Saguenay type spastic ataxia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4117815" SubmissionDate="2022-03-15" DateLastUpdated="2022-03-19" DateCreated="2022-03-19">
        <ClinVarSubmissionID localKey="2022-01696|MONDO:0019064" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002105046" DateUpdated="2022-03-19" DateCreated="2022-03-19" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, The Hospital for Sick Children" OrgID="1043" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.5:c.4756_4760delAATCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0019064" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11183483</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3516499" SubmissionDate="2022-01-05" DateLastUpdated="2023-03-04" DateCreated="2021-08-19">
        <ClinVarSubmissionID localKey="GDXSV:219005" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001792145" DateUpdated="2023-03-04" DateCreated="2021-08-19" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation, as the last 2994 amino acids are replaced with 2 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 30460542, 26153042, 27871429)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:54426</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.4:c.4756_4760del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_24_20210817091645</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_79_20220105054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4228122" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4191745|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002212925" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27871429</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30460542</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19892370</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21745802</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn1586Tyrfs*3) in the SACS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 2994 amino acid(s) of the SACS protein. This variant is present in population databases (rs765361868, gnomAD 0.005%). This premature translational stop signal has been observed in individual(s) with clinical features of SACS-related conditions (PMID: 27871429, 30460542). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1202576). This variant disrupts a region of the SACS protein in which other variant(s) (p.Arg3903*) have been determined to be pathogenic (PMID: 19892370, 21745802). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.23913255_23913259del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4228122" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3516499" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4117815" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0019064" MappingRef="MONDO">
        <MedGen CUI="C0037773" Name="Hereditary spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4082356" TraitType="Disease" MappingType="Name" MappingValue="Charlevoix-Saguenay type spastic ataxia" MappingRef="Preferred">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

